Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies. uri icon

authors

  • Stuver, Robert
  • Gyurkocza, Boglarka
  • Hamilton, Audrey
  • Lin, Ya-Hui
  • Jakubowski, Ann A
  • Joffe, Erel
  • Landau, Heather L
  • Richard J Lin, MD, PhD
  • Mailankody, Sham
  • Palomba, M Lia
  • Park, Jae H
  • Shah, Gunjan L
  • Perales, Miguel-Angel
  • Ponce, Doris M
  • Ramanathan, Lakshmi V
  • Salles, Gilles A
  • Scordo, Michael
  • Seo, Susan K
  • Shah, Urvi A
  • Stein, Eytan M
  • Straus, David
  • Usmani, Saad Z
  • Korde, Neha S
  • Young, James W
  • Zelenetz, Andrew D
  • Noy, Ariela
  • Vardhana, Santosha A
  • Roeker, Lindsey E
  • Mato, Anthony R
  • Batlevi, Connie L
  • Chung, David J
  • Doddi, Sital
  • Falchi, Lorenzo

publication date

  • January 1, 2022